Skip to main content

Table 1 Basic information of the studies included in the meta-analysis

From: Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility

First author, Year [Ref.]

Race

Variation

Disease type

Sample

Control source

Assay

case

control

Bougle, 2012 [11]

Caucasian

rs1801274

ICU /pneummonia

198

2789

HB

Taqman

Dressen, 2018 [35]

Caucasian

rs35705950

IPF

1510

1874

HB

Sequencing

Endeman, 2009 [12]

Caucasian

rs1801274

CAP

200

313

PB

Taqman

Forthal, 2007 [13]

Mixed

rs1801274

AIDS/ pneumonia

80

478

HB

Allele-specific PCR

Horimasu, 2015 [36]

Asian

rs35705950

NSIP

30

310

PB

Taqman

   

IPF

44

310

PB

Taqman

 

Caucasian

rs35705950

NSIP

31

35

PB

Taqman

   

IPF

71

35

PB

Taqman

Johnson, 2017 [37]

Caucasian

rs35705950

IIP

60

134

NA

Taqman

Jonsson, 2006 [14]

Caucasian

rs1801274

C2D/pneumonia

30

200

PB

Allele-specific PCR/sequencing

Kinder, 2007 [15]

Mixed

rs1801274

SLE/pneumonia

42

217

HB

Pyrosequencing

Kishore, 2016 [38]

Caucasian

rs35705950

IPFa

41

96

PB

Sequenom MassARRAY

  

rs35705950

IPFb

33

96

PB

Sequenom MassARRAY

  

rs35705950

IPFc

36

96

PB

Sequenom MassARRAY

  

rs35705950

IPFd

51

96

PB

Sequenom MassARRAY

Ley, 2017 [39]

Mixed

rs35705950

CHPe

123

503

PB

Taqman

   

CHPf

65

503

PB

Taqman

   

IPFe

147

503

PB

Taqman

   

IPFf

126

503

PB

Taqman

Moens, 2006 [16]

Caucasian

rs1801274

pneumonia

55

100

Mixed

allelic discrimination

Noth, 2013 [8]

Mixed

rs35705950

IPFg

542

542

PB

Genome-Wide Human SNP array

   

IPFh

544

687

PB

iPLEX Gold Platform

   

IPFi

324

702

PB

iPLEX Gold Platform

Seibold, 2011 [23]

Mixed

rs35705950

IPF

492

322

PB

Sequenom iPLEX

   

FIP

83

322

PB

Sequenom iPLEX

Sole, 2011 [17]

Caucasian

rs1801274

pneumococcal CAP

319

1224

Mixed

ASRED

   

nonbacteremic CAP

234

1224

Mixed

ASRED

   

bacteremic CAP

85

1224

Mixed

ASRED

Stock, 2013 [40]

Caucasian

rs35705950

IPF

110

416

PB

Taqman

van, 2016 [41]

Caucasian

rs35705950

spIPF

115

249

PB

Taqman

   

FIP

55

249

PB

Taqman

   

iNSIP

43

249

PB

Taqman

   

CTD-IP

35

249

PB

Taqman

Wang, 2014 [42]

Asian

rs35705950

IPF

165

1013

PB

PCR-RFLP/Taqman/

sequencing

   

CTD-NSIP

191

1013

PB

PCR-RFLP/Taqman/sequencing

   

CTD-UIP

49

1013

PB

PCR-RFLP/Taqman/sequencing

   

pneumonia

103

1013

PB

PCR-RFLP/Taqman/sequencing

Wei, 2014 [43]

Caucasian

rs35705950

IPF

84

689

PB

Taqman

Yee, 2000 [18]

Mixed

rs1801274

bacteremic pneumonia

42

136

HB

quantitative flow cytometry

   

nonbacteremic pneumonia

28

136

HB

quantitative flow cytometry

Yuan, 2003 [19]

Caucasian

rs1801274

pneumonia

63

20

PB#

SSP

   

pneumonia

63

58

PB%

SSP

Zhang, 2011 [44]

Caucasian

rs35705950

IPFj

246

166

PB

Taqman

   

IPFk

95

636

PB

Taqman

Zuniga, 2012 [20]

Mixed

rs1801274

pneumonia

91

98

PB

Taqman

  1. Ref. reference, M major allele (A for rs1801274; G for rs35705950), m minor allele (G for rs1801274; T for rs35705950), ICU intensive care unit, IPF idiopathic pulmonary fibrosis, CAP community-acquired pneumonia, AIDS acquired immune deficiency syndrome, NSIP nonspecific interstitial pneumonia, IIP idiopathic interstitial pneumonia, C2D, homozygous C2 deficiency, SLE systemic lupus erythematosus, CHP chronic hypersensitivity pneumonitis, FIP familial interstitial pneumonia, spIPF sporadic type of idiopathic pulmonary fibrosis, iNSIP idiopathic non-specific interstitial pneumonia, CTD-IP connective tissue disease associated intersititial pneumonia, CTD-NSIP connective tissue diseases-nonspecific interstitial pneumonia pattern, CTD-UIP connective tissue diseases-usual interstitial pneumonia pattern, HB hospital-based, PB population-based, NA not available, ASRED allele-specific restriction enzyme digestion, PCR polymerase chain reaction, SNP single nucleotide polymorphism, SSP sequence specific PCR, RFLP restriction fragment length polymorphism
  2. a data of Czech Republic, b data of Germany, c data of Greece, d data of France,
  3. e data of University of California San Francisco, f data of University of Texas Southwestern,
  4. g stage one of genome-wide association study, h stage two of genome-wide association study,
  5. i stage three of genome-wide association study, j data of University of Pittsburgh, k, data of University of Chicago,
  6. # healthy control, % normal random blood donors